HCA (HCA) Shows Positive EBITDA Surprise and Improving Margins - Goldman Sachs

Go back to HCA (HCA) Shows Positive EBITDA Surprise and Improving Margins - Goldman Sachs

HCA Healthcare Reports Second Quarter 2022 Results

July 22, 2022 6:30 AM EDT

NASHVILLE, Tenn.--(BUSINESS WIRE)-- HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the second quarter ended June 30, 2022.

Key second quarter metrics (all percentage changes compare 2Q 2022 to 2Q 2021 unless otherwise noted):

Revenues totaled $14.820 billion Net income attributable to HCA Healthcare, Inc. totaled $1.155 billion, or $3.90 per diluted share Adjusted EBITDA totaled $3.042 billion Cash flows from operating activities totaled $1.630 billion Same facility admissions declined 1.2 percent and same facility equivalent admissions increased 0.5... More

HCA Healthcare Announces Partnership With the University of Texas at El Paso to Advance Diversity in Healthcare Leadership

July 21, 2022 8:30 AM EDT

Health system to donate $750,000 as part of $10 million commitment to expanding partnerships with HBCUs and HSIs

NASHVILLE, Tenn.--(BUSINESS WIRE)-- HCA Healthcare, Inc. (NYSE: HCA), one of the nations leading healthcare providers, today announced that it will donate $750,000 to The University of Texas at El Paso (UTEP) to create... More